title: Contrast-enhanced MR imaging in the indirect monitoring of drug release from an interstitial depot.
authors.affiliation: Unit Pharmacology of Cancer Treatment, German Cancer Research Center, Heidelberg, Germany. r.port@dkfz.de
authors.forename: R E
authors.initials: RE
authors.lastname: Port
authors.forename: C
authors.initials: C
authors.lastname: Schuster
authors.forename: C R
authors.initials: CR
authors.lastname: Port
authors.forename: P
authors.initials: P
authors.lastname: Bachert
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003287:Contrast Media / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D016903:Drug Monitoring / Q000379:methods*; D019786:Gadolinium DTPA / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D008081:Liposomes; D008279:Magnetic Resonance Imaging; D051381:Rats; D001084:Vidarabine Phosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003287:Contrast Media; D003692:Delayed-Action Preparations; D008081:Liposomes; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate; D019786:Gadolinium DTPA